These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 26102440)

  • 1. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
    Zhioua I; Semoun O; Lalloum F; Souied EH
    Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
    Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
    Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Implant in Chronic Diabetic Macular Edema Resistant to Intravitreal Ranibizumab Treatment.
    Yucel OE; Can E; Ozturk HE; Birinci H; Sullu Y
    Ophthalmic Res; 2017; 57(3):161-165. PubMed ID: 27926909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS.
    Ciulla TA; Hussain RM; Ciulla LM; Sink B; Harris A
    Retina; 2016 Jul; 36(7):1292-7. PubMed ID: 26583309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.
    Bandello F; Augustin A; Tufail A; Leaback R
    Eur J Ophthalmol; 2018 Nov; 28(6):697-705. PubMed ID: 29631435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
    Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
    Esen E; Sizmaz S; Demircan N
    Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
    Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
    Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
    Landré C; Zourdani A; Gastaud P; Baillif S
    J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL DEXAMETHASONE IMPLANTATION IN PATIENTS WITH DIFFERENT MORPHOLOGICAL DIABETIC MACULAR EDEMA HAVING INSUFFICIENT RESPONSE TO RANIBIZUMAB.
    Kaldırım H; Yazgan S; Atalay K; Gurez C; Savur F
    Retina; 2018 May; 38(5):986-992. PubMed ID: 28426623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The Reldex Study.
    Malclès A; Dot C; Voirin N; Agard É; Vié AL; Bellocq D; Denis P; Kodjikian L
    Retina; 2017 Apr; 37(4):753-760. PubMed ID: 27471826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.